Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC.
Leonetti A, Cervati V, Minari R, Scarlattei M, Verzè M, Peroni M, Pluchino M, Bonatti F, Perrone F, Mazzaschi G, Cosenza A, Gnetti L, Bordi P, Ruffini L, Tiseo M.
Leonetti A, et al.
Clin Lung Cancer. 2024 Dec;25(8):e436-e445.e9. doi: 10.1016/j.cllc.2024.07.016. Epub 2024 Aug 6.
Clin Lung Cancer. 2024.
PMID: 39198088